Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Cyst Fibros ; 3(2): 99-117, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15463893

RESUMO

BACKGROUND: Loss of cystic fibrosis transmembrane conductance regulator (CFTR) function in cystic fibrosis (CF) causes dysregulation of multiple ion channels, water channels, and acid-base transporters in epithelia. As such, we hypothesized that dysregulation of many critical ion channels and transporters may cause defects in human airway epithelial cell volume regulation. METHODS: Cell volume, regulatory volume decrease, and its regulation was assessed in real-time via Coulter Counter Multisizer III-driven electronic cell sizing in non-CF, CF, and CFTR-complemented CF human airway epithelial cells. SPQ halide fluorescence assay of hypotonicity-induced chloride efflux provided indirect validation of the cell volume assays. RESULTS: CFTR, via autocrine ATP signaling, governs human airway epithelial cell volume regulation. Non-CF cells and wild-type (WT)-CFTR-transfected CF cells had normal regulatory volume decrease (RVD) responses that were attenuated by blockade of autocrine and paracrine purinergic signaling. In contrast, parental IB3-1 CF cells or IB3-1 cells expressing CFTR mutants (DeltaF508, G551D, and S1455X) failed to RVD. CF cell RVD was rescued by agonists to P2Y G protein-coupled receptors and, more robustly, by agonists to P2X purinergic receptor channels. CONCLUSIONS: Loss of CFTR and CFTR-driven autocrine ATP signaling may underlie defective cell volume regulation and dysregulated ion, water, and acid-base transport in CF airway epithelia.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Fibrose Cística/metabolismo , Receptores Purinérgicos P2/metabolismo , Mucosa Respiratória/metabolismo , Transdução de Sinais/fisiologia , Equilíbrio Hidroeletrolítico/fisiologia , Trifosfato de Adenosina/metabolismo , Comunicação Autócrina/fisiologia , Brônquios/citologia , Cálcio/metabolismo , Linhagem Celular , Cloretos/metabolismo , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Expressão Gênica , Humanos , Soluções Hipotônicas/farmacologia , Soluções Isotônicas/farmacologia , Mucosa Respiratória/citologia , Transfecção
2.
Am J Physiol Renal Physiol ; 282(4): F763-75, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11880338

RESUMO

ATP and its metabolites are potent autocrine agonists that act extracellularly within tissues to affect epithelial function. In polycystic kidneys, renal tubules become dilated and/or encapsulated as cysts, creating abnormal microenvironments for autocrine signaling. Previously, our laboratory has shown that high-nanomolar to micromolar quantities of ATP are released from cell monolayers in vitro and detectable in cyst fluids from microdissected human autosomal dominant polycystic kidney (ADPKD) cysts. Here, we show enhanced ATP release from autosomal recessive polycystic kidney (ARPKD) and ADPKD epithelial cell models. RT-PCR and immunoblotting for P2Y G protein-coupled receptors and P2X purinergic receptor channels show expression of mRNA and/or protein for multiple subtypes from both families. Assays of cytosolic Ca(2+) concentration and secretory Cl(-) transport show P2Y and P2X purinergic receptor-mediated stimulation of Cl(-) secretion via cytosolic Ca(2+)-dependent signaling. Therefore, we hypothesize that autocrine purinergic signaling may augment detrimentally cyst volume expansion in ADPKD or tubule dilation in ARPKD, accelerating disease progression.


Assuntos
Comunicação Autócrina/fisiologia , Células Epiteliais/fisiologia , Espaço Extracelular/fisiologia , Doenças Renais Policísticas/patologia , Receptores Purinérgicos P2/fisiologia , Adenosina Trifosfatases/metabolismo , Trifosfato de Adenosina/fisiologia , Animais , Cálcio/metabolismo , Linhagem Celular , Cloretos/metabolismo , DNA Complementar/biossíntese , DNA Complementar/genética , Corantes Fluorescentes , Fura-2 , Humanos , Medições Luminescentes , Camundongos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
3.
J Biol Chem ; 279(11): 10720-9, 2004 Mar 12.
Artigo em Inglês | MEDLINE | ID: mdl-14701827

RESUMO

Cystic fibrosis (CF) is caused by defective cyclic AMP-dependent cystic fibrosis transmembrane conductance regulator Cl(-) channels. Thus, CF epithelia fail to transport Cl(-) and water. A postulated therapeutic avenue in CF is activation of alternative Ca(2+)-dependent Cl(-) channels. We hypothesized that stimulation of Ca(2+) entry from the extracellular space could trigger a sustained Ca(2+) signal to activate Ca(2+)-dependent Cl(-) channels. Cytosolic [Ca(2+)](i) was measured in non-polarized human CF (IB3-1) and non-CF (16HBE14o(-)) airway epithelial cells. Primary human CF and non-CF airway epithelial monolayers as well as Calu-3 monolayers were used to assess anion secretion. In vivo nasal potential difference measurements were performed in non-CF and two different CF mouse (DeltaF508 homozygous and bitransgenic gut-corrected but lung-null) models. Zinc and ATP induced a sustained, reversible, and reproducible increase in cytosolic Ca(2+) in CF and non-CF cells with chemistry and pharmacology most consistent with activation of P2X purinergic receptor channels. P2X purinergic receptor channel-mediated Ca(2+) entry stimulated sustained Cl(-) and HCO(3)(-) secretion in CF and non-CF epithelial monolayers. In non-CF mice, zinc and ATP induced a significant Cl(-) secretory response similar to the effects of agonists that increase intracellular cAMP levels. More importantly, in both CF mouse models, Cl(-) permeability of nasal epithelia was restored in a sustained manner by zinc and ATP. These effects were reversible and reacquirable upon removal and readdition of agonists. Our data suggest that activation of P2X calcium entry channels may have profound therapeutic benefit for CF that is independent of cystic fibrosis transmembrane conductance regulator genotype.


Assuntos
Trifosfato de Adenosina/metabolismo , Cálcio/metabolismo , Cloretos/metabolismo , Fibrose Cística/metabolismo , Células Epiteliais/metabolismo , Traqueia/metabolismo , Zinco/farmacologia , Animais , Ânions , Linhagem Celular , Células Cultivadas , Cloro/metabolismo , Corantes/metabolismo , AMP Cíclico/metabolismo , Fibrose Cística/tratamento farmacológico , Regulador de Condutância Transmembrana em Fibrose Cística/genética , Citosol/metabolismo , Fura-2/farmacologia , Genótipo , Homozigoto , Humanos , Concentração de Íons de Hidrogênio , Camundongos , Mutação , Receptores Purinérgicos P2/metabolismo , Fatores de Tempo , Zinco/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA